These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14515833)

  • 1. Serum alanine aminotransferase concentrations in patients with Kawasaki disease.
    Uehara R; Yashiro M; Hayasaka S; Oki I; Nakamura Y; Muta H; Ishii M; Matsuishi T; Sonobe T; Yanagawa H
    Pediatr Infect Dis J; 2003 Sep; 22(9):839-42. PubMed ID: 14515833
    [No Abstract]   [Full Text] [Related]  

  • 2. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):501.e1-11; quiz 511-2. PubMed ID: 24034379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular involvement in Kawasaki disease.
    Narayanan SN; Ahamed MZ; Safia M
    Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Kawasaki disease incidence rising in Chandigarh, North India?
    Singh S; Aulakh R; Bhalla AK; Suri D; Manojkumar R; Narula N; Burns JC
    Arch Dis Child; 2011 Feb; 96(2):137-40. PubMed ID: 20923951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
    Koyanagi H; Nakamura Y; Yanagawa H
    Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A master role for neutrophils in Kawasaki syndrome.
    Andreozzi L; Bracci B; D'Errico F; Rigante D
    Immunol Lett; 2017 Apr; 184():112-114. PubMed ID: 28219676
    [No Abstract]   [Full Text] [Related]  

  • 9. Kawasaki syndrome.
    Melish ME
    Pediatr Rev; 1996 May; 17(5):153-62. PubMed ID: 8935914
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease.
    Yanagawa H; Tuohong Z; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
    Pediatr Cardiol; 1999; 20(4):248-51. PubMed ID: 10368448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facial palsy in a 2-month-old infant with Kawasaki disease.
    Thapa R
    Rheumatol Int; 2011 Feb; 31(2):277-8. PubMed ID: 20066423
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Kong WX; Ma FY; Fu SL; Wang W; Xie CH; Zhang YY; Gong FQ
    World J Pediatr; 2019 Apr; 15(2):168-175. PubMed ID: 30809758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kawasaki disease epidemiology in Guadeloupe].
    Tourneux P; Dufillot D; Belloy M; Boralevi F; Cevallos L; Krim G
    Presse Med; 2005 Jan; 34(1):25-8. PubMed ID: 15685094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical features of incomplete Kawasaki disease.
    Fukushige J; Takahashi N; Ueda Y; Ueda K
    Acta Paediatr; 1994 Oct; 83(10):1057-60. PubMed ID: 7841704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease in a US army soldier highlights surveillance.
    Chang C; Wood JC; Strickling WA; Walsh DS
    Int J Dermatol; 2006 Jan; 45(1):83-4. PubMed ID: 16426385
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
    Lee KY; Han JW; Lee HS; Hong JH; Hahn SH; Lee JS; Whang KT
    Pediatr Infect Dis J; 2004 Jan; 23(1):52-5. PubMed ID: 14743047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki disease.
    Kim DS
    Yonsei Med J; 2006 Dec; 47(6):759-72. PubMed ID: 17191303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
    Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological survey of Kawasaki disease in Sichuan province of China.
    Li XH; Li XJ; Li H; Xu M; Zhou M
    J Trop Pediatr; 2008 Apr; 54(2):133-6. PubMed ID: 17965438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease.
    Yoshida M; Oana S; Masuda H; Ishiguro A; Kato H; Ito S; Kobayashi T; Abe J
    Clin Pediatr (Phila); 2018 Feb; 57(2):189-192. PubMed ID: 28952328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.